Breast Cancer during pregnancy

Breast cancer during pregnancy is a rare but challenging condition, affecting about 1 in 3,000 pregnancies. Diagnosing breast cancer during pregnancy requires balancing the need for prompt treatment with the safety of the developing fetus. Treatment approaches depend on the stage of pregnancy and cancer, aiming to achieve the best possible outcomes for both mother and baby. Options may include surgery, chemotherapy (often delayed until after the first trimester), radiation therapy (carefully targeted to minimize fetal exposure), and hormone therapy (used cautiously due to potential effects on the fetus). Multidisciplinary teams coordinate care to optimize treatment decisions while supporting maternal and fetal health. Research continues to explore optimal management strategies and outcomes for pregnant women with breast cancer, emphasizing personalized approaches and shared decision-making between healthcare providers and patients.

    Related Conference of Breast Cancer during pregnancy

    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    44th Euro Congress on Cancer Science & Therapy

    Paris, France
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK

    Breast Cancer during pregnancy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in